Lam Research Corp (LRCX)
Official siteTECHNOLOGY • SEMICONDUCTOR EQUIPMENT & MATERIALS • NASDAQ
Market Cap: $282.21B
Last updated: Nov 17, 2026 at 11:06 AM ET
Lam Research Corp (LRCX) Financials: Revenue, Profit and Cash Flow
Lam Research reported revenue of $23.23B for the fiscal year ended Jun 30, 2026, up 26.0% from the year before. That year, net income was $7.27B with a net margin of 31.3%, operating cash flow was $5.86B and free cash flow was $4.89B. The quarter ended Sep 30, 2026 had revenue of $8.22B and net income of $2.75B.
Revenue and Margins
The operating margin was 35.3% in the fiscal year ended Jun 2026, the highest of the 10 years shown. Over the 9 years to Jun 2026, revenue grew from $8.01B, a compound annual rate of 12.6%.
| Fiscal year | Revenue | Growth | Gross margin | Operating margin | Net margin |
|---|---|---|---|---|---|
| Jun 2026 | $23.23B | +26.0% | 50.5% | 35.3% | 31.3% |
| Jun 2025 | $18.44B | +23.7% | 48.7% | 32.0% | 29.1% |
| Jun 2024 | $14.91B | -14.5% | 47.3% | 28.6% | 25.7% |
| Jun 2023 | $17.43B | +1.2% | 44.6% | 29.7% | 25.9% |
| Jun 2022 | $17.23B | +17.8% | 45.7% | 31.2% | 26.7% |
| Jun 2021 | $14.63B | +45.6% | 46.5% | 30.6% | 26.7% |
| Jun 2020 | $10.04B | +4.1% | 45.9% | 26.6% | 22.4% |
| Jun 2019 | $9.65B | -12.9% | 45.1% | 25.5% | 22.7% |
| Jun 2018 | $11.08B | +38.2% | 46.6% | 29.0% | 21.5% |
| Jun 2017 | $8.01B | N/A | 45.0% | 23.7% | 21.2% |
Income Statement
In the fiscal year ended Jun 2026, net income rose 35.6% from the year before. In the quarter ended Sep 2026, net income rose 75.2% from the same quarter a year earlier.
Annual
| Line item | Jun 2026 | Jun 2025 | Jun 2024 | Jun 2023 | Jun 2022 | Jun 2021 | Jun 2020 | Jun 2019 | Jun 2018 | Jun 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $23.23B | $18.44B | $14.91B | $17.43B | $17.23B | $14.63B | $10.04B | $9.65B | $11.08B | $8.01B |
| Cost of revenue | $11.51B | $9.46B | $7.85B | $9.65B | $9.36B | $7.82B | $5.44B | $5.30B | $5.91B | $4.41B |
| Gross profit | $11.73B | $8.98B | $7.05B | $7.78B | $7.87B | $6.81B | $4.61B | $4.36B | $5.17B | $3.60B |
| Research and development | $2.38B | $2.10B | $1.90B | $1.73B | $1.60B | $1.49B | $1.25B | $1.19B | $1.19B | $1.03B |
| Operating income | $8.20B | $5.90B | $4.26B | $5.17B | $5.38B | $4.48B | $2.67B | $2.46B | $3.21B | $1.90B |
| Net income | $7.27B | $5.36B | $3.83B | $4.51B | $4.61B | $3.91B | $2.25B | $2.19B | $2.38B | $1.70B |
| EBITDA | $8.70B | $6.34B | $4.72B | $5.45B | $5.53B | $4.68B | $2.84B | $2.76B | $3.49B | $2.14B |
Quarterly
| Line item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $8.22B | $6.72B | $5.84B | $5.34B | $5.32B | $5.17B | $4.72B | $4.38B | $4.17B | $3.87B | $3.79B | $3.76B |
| Gross profit | $4.30B | $3.48B | $2.91B | $2.65B | $2.68B | $2.59B | $2.31B | $2.07B | $2.00B | $1.84B | $1.80B | $1.76B |
| Operating income | $3.28B | $2.51B | $2.05B | $1.81B | $1.83B | $1.74B | $1.56B | $1.33B | $1.26B | $1.13B | $1.06B | $1.06B |
| Net income | $2.75B | $2.28B | $1.83B | $1.59B | $1.57B | $1.72B | $1.33B | $1.19B | $1.12B | $1.02B | $965.83M | $954.27M |
Balance Sheet
As of Jun 2026, cash and equivalents exceeded total debt of $3.73B by $1.84B.
Annual
| Line item | Jun 2026 | Jun 2025 | Jun 2024 | Jun 2023 | Jun 2022 | Jun 2021 | Jun 2020 | Jun 2019 | Jun 2018 | Jun 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | $23.53B | $21.35B | $18.74B | $18.78B | $17.20B | $15.89B | $14.56B | $12.00B | $12.48B | $12.12B |
| Current assets | $15.61B | $14.52B | $12.88B | $13.23B | $12.29B | $11.65B | $10.85B | $8.56B | $9.15B | $9.14B |
| Cash and equivalents | $5.58B | $6.39B | $5.85B | $5.34B | $3.52B | $4.42B | $4.92B | $3.66B | $4.51B | $2.38B |
| Total liabilities | $11.06B | $11.48B | $10.21B | $10.57B | $10.92B | $9.86B | $9.38B | $7.28B | $5.90B | $5.14B |
| Short-term debt | $4.07M | $754.31M | $504.81M | $8.36M | $7.38M | $11.35M | $839.88M | $667.13M | $610.03M | $908.44M |
| Long-term debt | $3.73B | $3.73B | $4.48B | $5.00B | $5.00B | $4.99B | $4.97B | $3.82B | $1.81B | $1.78B |
| Shareholder equity | $12.47B | $9.86B | $8.54B | $8.21B | $6.28B | $6.03B | $5.17B | $4.67B | $6.50B | $6.82B |
Quarterly
| Line item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | $26.35B | $23.53B | $20.79B | $21.39B | $21.90B | $21.35B | $19.97B | $19.84B | $19.53B | $18.74B | $18.28B | $18.78B |
| Total liabilities | $12.44B | $11.06B | $10.21B | $11.25B | $11.71B | $11.48B | $10.46B | $11.03B | $11.06B | $10.21B | $10.26B | $10.56B |
| Cash and equivalents | $7.44B | $5.58B | $4.75B | $6.18B | $6.69B | $6.39B | $5.45B | $5.67B | $6.07B | $5.85B | $5.67B | $5.62B |
| Shareholder equity | $13.91B | $12.47B | $10.58B | $10.15B | $10.19B | $9.86B | $9.51B | $8.81B | $8.47B | $8.54B | $8.02B | $8.22B |
Cash Flow
In the fiscal year ended Jun 2026, free cash flow was 83.4% of operating cash flow. Dividends and share repurchases together came to 104.7% of it.
Annual
| Line item | Jun 2026 | Jun 2025 | Jun 2024 | Jun 2023 | Jun 2022 | Jun 2021 | Jun 2020 | Jun 2019 | Jun 2018 | Jun 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $5.86B | $6.17B | $4.65B | $5.18B | $3.10B | $3.59B | $2.13B | $3.18B | $2.66B | $2.03B |
| Capital expenditures | $966.40M | $759.19M | $396.67M | $501.57M | $546.03M | $349.10M | $203.24M | $303.49M | $273.47M | $157.42M |
| Free cash flow | $4.89B | $5.41B | $4.26B | $4.68B | $2.55B | $3.24B | $1.92B | $2.87B | $2.38B | $1.87B |
| Dividends paid | $1.27B | $1.15B | $1.02B | $907.91M | $815.29M | $726.99M | $656.84M | $678.35M | $307.61M | $243.50M |
| Share repurchases | $3.85B | $3.42B | $2.84B | $2.02B | $3.87B | $2.70B | $1.37B | $3.78B | $2.65B | $811.67M |
| Investing cash flow | -$922.15M | -$708.09M | -$370.61M | -$534.56M | $612.27M | $73.27M | -$244.08M | -$1.64B | $2.75B | -$2.05B |
| Financing cash flow | -$5.72B | -$4.94B | -$4.00B | -$2.83B | -$4.58B | -$4.17B | -$623.93M | -$2.39B | -$3.27B | -$2.63B |
Quarterly
| Line item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $3.50B | $1.46B | $1.14B | $1.48B | $1.78B | $2.55B | $1.31B | $741.94M | $1.57B | $862.43M | $1.38B | $1.45B |
| Capital expenditures | $257.70M | $188.80M | $331.60M | $260.88M | $185.12M | $172.19M | $288.06M | $188.35M | $110.59M | $100.75M | $103.65M | $115.28M |
| Free cash flow | $3.24B | $1.27B | $809.82M | $1.22B | $1.59B | $2.38B | $1.02B | $553.59M | $1.46B | $761.68M | $1.28B | $1.34B |
Frequently Asked Questions About LRCX
What is Lam Research's annual revenue?
Lam Research reported revenue of $23.23B for the fiscal year ended Jun 30, 2026.
How fast is Lam Research's revenue growing?
Revenue was up 26.0% for the fiscal year ended Jun 30, 2026 compared with the year before. The compound annual revenue growth rate over 3 years was 10.1%.
Is Lam Research profitable?
Yes. Lam Research reported net income of $7.27B for the fiscal year ended Jun 30, 2026, with a net margin of 31.3%.
How much free cash flow does LRCX generate?
For the fiscal year ended Jun 30, 2026, operating cash flow of $5.86B minus capital expenditures of $966.40M produced free cash flow of $4.89B.
How much debt does Lam Research have?
The balance sheet dated Jun 30, 2026 reported long-term debt of $3.73B, short-term debt of $4.07M and cash and equivalents of $5.58B.
LRCX pages: Overview, Dividends, Earnings, Forecast, Financials, Valuation, Competitors